v3.25.4
Segmental Reporting - Schedule of Reportable Segment Net Loss (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Segment Reporting Information [Line Items]    
License revenue $ 4,089 $ 308
Research ad Development    
Research & development expense   900
General and Administrative    
General and administrative expense 65,088 47,544
Interest income 1,478 778
Interest expense (1,162) (3,124)
Net loss (660,147) (150,049)
Reportable Segment    
General and Administrative    
Interest income 1,478 778
Interest expense (1,162) (3,124)
Other segment items [1] (16,402) (45,012)
Net loss (660,147) (150,049)
License Revenue    
Segment Reporting Information [Line Items]    
License revenue 202 308
Research and Development Services Revenue    
Segment Reporting Information [Line Items]    
License revenue 3,887 0
Research and Development Services Revenue | Reportable Segment    
Segment Reporting Information [Line Items]    
License revenue 3,887 0
BPL-003 | Reportable Segment    
Research ad Development    
Research & development expense 1,283 0
VLS-01 | Reportable Segment    
Research ad Development    
Research & development expense 16,297 10,606
EMP-01 | Reportable Segment    
Research ad Development    
Research & development expense 7,894 1,527
Discovery (Non-hallucinogenic) | Reportable Segment    
Research ad Development    
Research & development expense 2,323 2,649
Other Programs | Reportable Segment    
Research ad Development    
Research & development expense [2] 8,574 16,956
Personnel and Employee-related Expenses | Reportable Segment    
Research ad Development    
Research & development expense [3] 10,775 10,545
General and Administrative    
General and administrative expense [3] 14,109 12,493
Non-cash Share-based Compensation Expense | Reportable Segment    
Research ad Development    
Research & development expense 10,163 14,767
General and Administrative    
General and administrative expense 4,026 10,390
Depreciation | Reportable Segment    
Research ad Development    
Research & development expense 662 184
General and Administrative    
General and administrative expense 350 290
Other Expenses | Reportable Segment    
Research ad Development    
Research & development expense [4] 531,228 2,597
General and Administrative    
General and administrative expense [4] 11,373 6,715
Accounting and Tax Fees | Reportable Segment    
General and Administrative    
General and administrative expense 8,118 5,057
Legal & Intellectual Property Fees | Reportable Segment    
General and Administrative    
General and administrative expense 19,437 5,895
Insurance | Reportable Segment    
General and Administrative    
General and administrative expense $ 1,538 $ 2,328
[1] Includes change in fair value of assets and liabilities, net, gain on other investments, Gain on the consolidation of Beckley Psytech, change in the fair value of digital assets, net, foreign exchange gains (losses), net, other income (expense), net, benefit (provision) for income taxes, and losses from investments in equity method investees, net of tax.
[2] Includes direct expenses related to RL-007, PCN-101, KUR-101, RLS-01, EGX-121, and enabling technologies programs and external R&D costs incurred by Nualtis. There were no direct expenses incurred in 2025 related to the RLS-01 and KUR-101 programs
[3] Includes labor, benefits, and personnel-based restructuring expenses.
[4] Includes public company fees, professional consulting services, facilities costs, technology and communication costs, and miscellaneous fees.